Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Croft

Showing results (31-40 of 182) with videos related to

Pageof 19
Sort By:
European Journal of Immunology|February 6, 2002
4-1BB (CD137) controls the clonal expansion and survival of CD8 T cells in vivo but does not contribute to the development of cytotoxicityDavid Cooper, Pratima Bansal-Pakala, Michael Croft
Allergy|August 31, 2023
TNF-like weak inducer of apoptosis inhibition is comparable to IL-13 blockade in ameliorating atopic dermatitis inflammationRinkesh K Gupta, Jacqueline Miller, Michael Croft
Cytokine & Growth Factor Reviews|May 30, 2008
Immune regulation and control of regulatory T cells by OX40 and 4-1BBTakanori So, Seung-Woo Lee, Michael Croft
Viral Immunology|October 1, 2011
Preferential replication of vaccinia virus in the ovaries is independent of immune regulation through IL-10 and TGF-βYuan Zhao, Yan Fei Adams, Michael Croft
Frontiers in Immunology|August 8, 2022
Contribution of circulatory cells to asthma exacerbations and lung tissue-resident CD4 T cell memoryGurupreet S Sethi, Donald Gracias, Michael Croft
Frontiers in Immunology|September 4, 2023
Agonism of 4-1BB for immune therapy: a perspective on possibilities and complicationsShahram Salek-Ardakani, Dirk M Zajonc, Michael Croft
Journal of Medical Imaging and Radiation Oncology|November 20, 2021
Optimising CT-chest protocols and the added value of venous-phase contrast timing; Observational case-controlMichael Croft, WanYin Lim, Nusha Lavender, et al.
Nature Reviews. Drug Discovery|October 25, 2024
Targeting the TNF and TNFR superfamilies in autoimmune disease and cancerMichael Croft, Shahram Salek-Ardakani, Carl F Ware
The Journal of Experimental Medicine|May 23, 2022
Realigning the LIGHT signaling network to control dysregulated inflammationCarl F Ware, Michael Croft, Garry A Neil
Nature Reviews. Drug Discovery|January 22, 2013
Clinical targeting of the TNF and TNFR superfamiliesMichael Croft, Chris A Benedict, Carl F Ware
Pageof 19

Showing results (31-40 of 182) with videos related to

Sort By:
Pageof 19
European Journal of Immunology|February 6, 2002
4-1BB (CD137) controls the clonal expansion and survival of CD8 T cells in vivo but does not contribute to the development of cytotoxicityDavid Cooper, Pratima Bansal-Pakala, Michael Croft
Allergy|August 31, 2023
TNF-like weak inducer of apoptosis inhibition is comparable to IL-13 blockade in ameliorating atopic dermatitis inflammationRinkesh K Gupta, Jacqueline Miller, Michael Croft
Cytokine & Growth Factor Reviews|May 30, 2008
Immune regulation and control of regulatory T cells by OX40 and 4-1BBTakanori So, Seung-Woo Lee, Michael Croft
Viral Immunology|October 1, 2011
Preferential replication of vaccinia virus in the ovaries is independent of immune regulation through IL-10 and TGF-βYuan Zhao, Yan Fei Adams, Michael Croft
Frontiers in Immunology|August 8, 2022
Contribution of circulatory cells to asthma exacerbations and lung tissue-resident CD4 T cell memoryGurupreet S Sethi, Donald Gracias, Michael Croft
Frontiers in Immunology|September 4, 2023
Agonism of 4-1BB for immune therapy: a perspective on possibilities and complicationsShahram Salek-Ardakani, Dirk M Zajonc, Michael Croft
Journal of Medical Imaging and Radiation Oncology|November 20, 2021
Optimising CT-chest protocols and the added value of venous-phase contrast timing; Observational case-controlMichael Croft, WanYin Lim, Nusha Lavender, et al.
Nature Reviews. Drug Discovery|October 25, 2024
Targeting the TNF and TNFR superfamilies in autoimmune disease and cancerMichael Croft, Shahram Salek-Ardakani, Carl F Ware
The Journal of Experimental Medicine|May 23, 2022
Realigning the LIGHT signaling network to control dysregulated inflammationCarl F Ware, Michael Croft, Garry A Neil
Nature Reviews. Drug Discovery|January 22, 2013
Clinical targeting of the TNF and TNFR superfamiliesMichael Croft, Chris A Benedict, Carl F Ware
Pageof 19